Immune disease comorbidities

PheWeb

PULM_IMMUNECOMORB

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries None

Check pre-conditions, main-only, mode, ICD version None

Check minimum number of events None

Include endpoints

K11_IBD

M13_SYSTCONNECT

K11_OTHENTERCOL

M13_RHEUMA

30367

PULM_IMMUNECOMORB

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Immune disease comorbidities based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	29510	18722	10788
Unadjusted prevalence (%)	9.56	10.79	7.99
Mean age at first event (years)	48.97	47.71	51.17

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.03	2.12 [1.87, 2.39]	1.9e-32	2969
15 years	0.01	1.27 [1.13, 1.43]	5.9e-5	1284
5 years	0.00	2.36 [2.10, 2.65]	2.1e-47	768
1 year	0.00	6.04 [5.19, 7.02]	<1e-100	398

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: PULM_IMMUNECOMORB – Immune disease comorbidities
GWS hits:

Survival analyses between endpoints

↥

Plot

before Immune disease comorbidities
after Immune disease comorbidities

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Immune disease comorbidities

↥